Geode Capital Management’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $61.9K | Buy |
18,871
+3,365
| +22% | +$11K | ﹤0.01% | 4169 |
|
2025
Q1 | $43.3K | Sell |
15,506
-1,122
| -7% | -$3.13K | ﹤0.01% | 4225 |
|
2024
Q4 | $288K | Buy |
16,628
+1,914
| +13% | +$33.1K | ﹤0.01% | 3781 |
|
2024
Q3 | $401K | Buy |
14,714
+4,727
| +47% | +$129K | ﹤0.01% | 3681 |
|
2024
Q2 | $406K | Buy |
9,987
+3,297
| +49% | +$134K | ﹤0.01% | 3647 |
|
2024
Q1 | $446K | Buy |
6,690
+410
| +7% | +$27.3K | ﹤0.01% | 3660 |
|
2023
Q4 | $712K | Buy |
6,280
+580
| +10% | +$65.8K | ﹤0.01% | 3476 |
|
2023
Q3 | $1.04M | Buy |
5,700
+718
| +14% | +$131K | ﹤0.01% | 3303 |
|
2023
Q2 | $1.82M | Sell |
4,982
-4,675
| -48% | -$1.71M | ﹤0.01% | 3141 |
|
2023
Q1 | $6.43M | Buy |
9,657
+405
| +4% | +$270K | ﹤0.01% | 2519 |
|
2022
Q4 | $8.1M | Buy |
9,252
+484
| +6% | +$424K | ﹤0.01% | 2398 |
|
2022
Q3 | $9.63M | Buy |
8,768
+181
| +2% | +$199K | ﹤0.01% | 2292 |
|
2022
Q2 | $7.11M | Buy |
8,587
+1,266
| +17% | +$1.05M | ﹤0.01% | 2483 |
|
2022
Q1 | $11.3M | Sell |
7,321
-537
| -7% | -$831K | ﹤0.01% | 2268 |
|
2021
Q4 | $14.1M | Buy |
7,858
+71
| +0.9% | +$127K | ﹤0.01% | 2208 |
|
2021
Q3 | $25.7M | Sell |
7,787
-32
| -0.4% | -$106K | ﹤0.01% | 1780 |
|
2021
Q2 | $34.4M | Buy |
7,819
+5,026
| +180% | +$22.1M | ﹤0.01% | 1614 |
|
2021
Q1 | $13.5M | Buy |
2,793
+1,219
| +77% | +$5.91M | ﹤0.01% | 2142 |
|
2020
Q4 | $2.91M | Buy |
1,574
+547
| +53% | +$1.01M | ﹤0.01% | 2881 |
|
2020
Q3 | $400K | Buy |
1,027
+492
| +92% | +$192K | ﹤0.01% | 3490 |
|
2020
Q2 | $163K | Buy |
535
+123
| +30% | +$37.5K | ﹤0.01% | 3714 |
|
2020
Q1 | $112K | Sell |
412
-9
| -2% | -$2.45K | ﹤0.01% | 3728 |
|
2019
Q4 | $313K | Buy |
+421
| New | +$313K | ﹤0.01% | 3658 |
|